TY  - JOUR

T1  - 9341 CHAMPAIN Study: Initial Results From A Phase II Study Of Efficacy, Safety And Tolerability Of Modified-release Hydrocortisones: Chronocort® (Efmody®) Versus Plenadren®, In Primary Adrenal Insufficiency

JO  - Journal of the Endocrine Society

UR  - http://dx.doi.org/10.1210/jendso/bvae163.131

PY  - 2024/10/05

AU  - Prete A

AU  - Theiler-Schwetz V

AU  - Arlt W

AU  - Chifu IO

AU  - Harbeck B

AU  - Napier C

AU  - Newell-Price JD

AU  - Rees A

AU  - Reisch N

AU  - Stalla GK

AU  - Aslam N et al

ED  - 

DO  - DOI: 10.1210/jendso/bvae163.131

PB  - The Endocrine Society

VL  - 8

IS  - Supplement_1

Y2  - 2024/12/22

ER  -